Advancing excellence in laboratory medicine for better healthcare worldwide

Cell free DNA and related circulating biomarkers (WG-cfDNA)



Name Position Country Term Time in Office
R. van Schaik Chair NL 2nd  2021 01 - 2023 12
M. del Re Member  IT     
S. Galbiati Member  IT     
E. Lianidou Member  GR     
M. Neumaier Member DE    
D. Lo Member HK     
M. Oellerich Member  DE     


Terms of Reference

  • To identify and provide guidance on preanalytical and analytical aspects for obtaining good and reproducible results for cfDNA and related circulating biomarkers for clinical use, and to guide the correct clinical implementation of these biomarkers.


Current projects

  • a) Defining pre-analytical aspects / drafting guideline
  • b) Defining minimal analytical performance
  • c) Setting up proficiency testing for cfDNA
  • e) Organizing international workshops
  • f) Defining grant proposals to address unmet needs under a) and b)



List of Corresponding Members, nominated by National Societies

Name Full and Affiliate Member Societies
Oytun Portakal Turkish Biochemical Society (TBS)


List of Corresponding Members, nominated by Corporate Members

Name Corporate Members
Laura Vaahtoranta MEDIX BIOCHEMICA
Mana Javey ROCHE 



Working Group Chair's contact

Professor of Pharmacogenetic
Erasmus University Medical Center Rotterdam
Room Na-415 - Wytemaweg 80
3015CN Rotterdam
The Netherlands
Tel.: +31 10 70 33119


Website developed by Insoft